On March 6, 2025, the Connecticut State Legislature introduced Senate Bill 11, a significant piece of legislation aimed at reforming the operations of pharmacy benefits managers (PBMs) in the state. This bill seeks to enhance transparency and accountability in the healthcare system, particularly concerning the management of prescription drug benefits.

The primary purpose of Senate Bill 11 is to address conflicts of interest that may arise between PBMs and health carriers, ensuring that the interests of patients and consumers are prioritized. Key provisions of the bill require PBMs to notify health carriers of any activities or policies that could present a conflict of interest. Additionally, the bill mandates that PBMs act in good faith and fair dealing with all parties involved, including health carriers and plan sponsors.

One of the most notable aspects of the bill is its emphasis on fiduciary duties. It prohibits contracts that would allow health carriers to violate their fiduciary responsibilities to their covered persons. This provision aims to protect consumers from potential exploitation and ensure that their healthcare needs are met without undue influence from PBMs.

The bill has sparked discussions among lawmakers, healthcare professionals, and advocacy groups. Supporters argue that it is a necessary step toward greater accountability in the pharmaceutical industry, which has faced scrutiny over rising drug prices and opaque practices. Critics, however, express concerns about the potential for increased administrative burdens on PBMs and health carriers, which could lead to higher costs for consumers.

The implications of Senate Bill 11 extend beyond regulatory compliance; they touch on broader economic and social issues, including healthcare affordability and access to medications. Experts suggest that if passed, the bill could lead to more competitive pricing for prescription drugs, ultimately benefiting consumers.

As the legislative process unfolds, stakeholders will be closely monitoring the bill's progress and its potential impact on the healthcare landscape in Connecticut. The outcome of Senate Bill 11 could set a precedent for how pharmacy benefits are managed, influencing similar reforms in other states. The bill is scheduled for further discussion in upcoming legislative sessions, where its provisions may be debated and amended before a final vote.